Some channels such as the neonatal splice variant of Nav1.5 (nNav1.5) in, e.g., primary breast cancer cells, or mutated PANX1 (PANX11−98) in circulating cancer cells, seem to be highly cancer cell-associated and might be used to specifically target cancer cells in the future. Here, PANX1 is linked to breast carcinoma.